ACM
Avalon Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,796
| Closed | -$2.3M | – | 138 |
|
|
2024
Q3 | $2.3M | Buy |
+15,796
| New | +$2.3M | 0.7% | 33 |
|
|
2021
Q3 | – | Sell |
-23,838
| Closed | -$3.9M | – | 48 |
|
|
2021
Q2 | $3.9M | Buy |
+23,838
| New | +$3.9M | 3.29% | 14 |
|
|
2017
Q2 | – | Sell |
-7,007
| Closed | -$2.06M | – | 86 |
|
|
2017
Q1 | $2.06M | Buy |
+7,007
| New | +$2.06M | 1.42% | 23 |
|
|
2016
Q2 | – | Sell |
-3,594
| Closed | -$937K | – | 87 |
|
|
2016
Q1 | $937K | Buy |
3,594
+683
| +23% | +$178K | 0.75% | 38 |
|
|
2015
Q4 | $985K | Buy |
+2,911
| New | +$985K | 0.89% | 42 |
|
|
2014
Q3 | – | Sell |
-4,570
| Closed | -$1.18M | – | 84 |
|
|
2014
Q2 | $1.18M | Buy |
+4,570
| New | +$1.18M | 0.98% | 34 |
|
|
2013
Q4 | – | Sell |
-1,764
| Closed | -$370K | – | 112 |
|
|
2013
Q3 | $370K | Buy |
+1,764
| New | +$370K | 0.37% | 70 |
|